• 03/31/2023

    PAION AG implements resolved capital reduction

  • 03/30/2023

    PAION AG reports on fiscal year 2022

  • 03/16/2023

    PAION IS HOSTING A SPONSORED ANGIOTENSIN II SYMPOSIUM AT ISICEM IN BRUSSELS

  • 01/25/2023

    Extraordinary General Meeting approves capital reductions and creates scope for further corporate financing

  • 01/25/2023

    PAION AG: Extraordinary General Meeting approves capital reductions and creates scope for further corporate financing

  • 01/19/2023

    ​​​​​​​PAION ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BY ITS LICENSEE CRISTÁLIA IN BRASIL